Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial

Patients with ≥severe TR benefit from TTVR, experiencing improvements in TR severity, functional capacity, and quality of life regardless of baseline TR severity, with a signal for greater benefit in patients with more advanced disease.